CNBX Pharmaceuticals Inc. reported earnings results for the first quarter ended November 30, 2021. For the first quarter, the company reported net loss was USD 1.32 million compared to USD 0.654767 million a year ago. Basic loss per share from continuing operations was USD 1.2 compared to USD 0.6 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0108 USD | -16.92% | -5.26% | -23.94% |
1st Jan change | Capi. | |
---|---|---|
-23.94% | 336K | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- CNBX Stock
- News CNBX Pharmaceuticals Inc.
- CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021